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Abstract Using radiolysis with 32P enriched phosphate as an
internal source of ionizing radiation, the formation of hydro-
peroxo-ferric complex from oxy-ferrous precursor with a high
yield was monitored at 77 K in heme oxygenase (HO) by means
of optical absorption spectroscopy. Well-resolved absorption
spectra (maxima at 421 nm, 530 nm, 557 nm) of hydroper-
oxo-ferric intermediate of this heme enzyme were measured in
70% glycerol/bu¡er frozen glasses. After annealing at 210^
215 K this complex converts to the product complex, K-meso
hydroxyheme-HO. No heme degradation products were formed
in control experiments with ferric HO or other heme proteins.
0 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
The cytochromes P450 [1], nitric oxide synthases [2], heme
oxygenases (HO) [3,4], and some other heme enzymes [5] are
able to activate molecular oxygen and to form a redox active
center. Other mononuclear heme enzymes (peroxidases, cata-
lases) use instead the reduced form of oxygen, hydrogen per-
oxide [6,7]. All these enzymes contain ferric protoporphyrin
IX, and form the same highly reactive intermediate, hydro-
peroxo-ferric heme complex (FeP-OOH), at the obligatory
step of the catalytic cycle towards the high valent oxoferryl
heme complexes [8,9]. The pivotal role of this intermediate in
oxygen activation catalysis is becoming widely recognized
[10,11] ; however, there is still not enough information about
its structure and properties because of the high reactivity and
low stability of FeP-OOH enzyme complexes [12^14] as well
as of porphyrin model compounds [15]. Up to now the iso-
lation of FeP-OOH intermediates in heme enzymes was
achieved mainly through radiolytic reduction of oxy-ferrous
precursors at 77 K [16^26].
Heme oxygenases catalyze the degradation of hemin and
may play an important role in the defensive mechanism
against oxidative stress [4]. The catalytic mechanism of HO
includes stepwise formation of hydroxyheme, verdoheme, and
K-biliverdin with concomitant release of CO and free iron.
Unlike in many other heme enzymes, the FeP-OOH complex
in HO is not an intermediate on the path towards the ferryl-
oxo porphyrin compound, but is itself the active complex at
the ¢rst step of HO catalytic cycle [3,4]. Recently, it was
prepared using cryoradiolysis, and characterized in detail by
means of electronic paramagnetic resonance (EPR) and elec-
tron nuclear double resonance (ENDOR) spectroscopy [23].
The primary product of heme catabolism, the K-meso hy-
droxyheme, was formed in this system when annealed above
200 K. However, the oxy-ferrous precursor and, possibly,
some product species in this reaction are diamagnetic and
could not be followed by EPR [23]. In this letter we use
optical spectroscopy at low temperatures and 32P phosphate
as an internal radiation source to monitor the gradual forma-
tion of FeP-OOH complex from oxy-ferrous HO with the
increase of absorbed dose, and to measure the absorption
spectrum of this intermediate.
2. Materials and methods
2.1. Materials
The wild type truncated water-soluble recombinant rat HO-1
(denoted HO) was expressed, puri¢ed, and reconstituted with hemin
according to published procedures [27]. 32P enriched phosphate
(aqueous solution, 50 mCi/ml activity, isotope half-life 14.26 days)
was purchased from Amersham Pharmacia Biotech. All other
chemicals (spectrophotometric grade) were obtained from Sigma-Al-
drich.
2.2. Sample preparation and cryogenic UV-VIS spectroscopy
Oxygenated HO was prepared by bubbling of oxygen or air through
the solution of ferrous HO in aqueous glycerol phosphate bu¡er
(0.1 M, pH 7.0). Ferrous HO was obtained by reduction of ferric
HO with dithionite in an anaerobic chamber and subsequent anaero-
bic chromatography (G-25 column) to remove excess dithionite. Ab-
sorption spectra were measured using a Cary 3 UV/Vis spectropho-
tometer in methacrylate semi-micro cells from Fisher used with a
pathlength 4.3 mm. Cryogenic measurements were done in a home-
made cryostat as described [25].
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2.3. Cryogenic reduction
Radiolytic reduction at 77 K was achieved by Q-irradiation of the
samples using the 60Co source (Notre Dame Radiation Laboratory,
Notre Dame University, South Bend, IN, USA) with the dose rate 11
kGy/hour for 4 h. Alternatively, the 32P enriched phosphate was used
as an internal source of ionizing radiation as we described in detail
earlier [24]. During dose accumulation with 32P, the reduction of oxy-
HO and formation of the FeP-OOH complex was monitored by ab-
sorption spectroscopy at 77 K. To do this, the background absorption
of the trapped electrons was photobleached prior to spectroscopic
measurements by illumination with the white light, using the ¢lter
absorbing at wavelengths 450 nm and shorter, to prevent possible
photolysis in the Soret region. The multiple photobleaching in the
course of dose accumulation signi¢cantly improves the yield of the
radiolytic reduction (see the discussion below).
3. Results and discussion
The inelastic (Compton) scattering of the high energy par-
ticles on the solvent molecules generates electrons and cation
radicals. In the frozen solvent matrix at 77 K the electrons
may be trapped in the potential wells created by solvent mol-
ecules [28]. The products of radiolysis are thus immobilized
and accumulated in the solvent matrix, although they may
later recombine with further generated radiolytic electrons,
which retain mobility before they are also trapped. The latter
reactions result in saturation behavior of the radiolytic yield
at a higher radiation dose [29], which is usually below 40% in
metalloprotein studies [30]. This limitation is due to accumu-
lation of the positive holes with the increase of the dose ab-
sorbed by the sample and the concurrent reactions of these
holes with the radiolytic electrons. The estimated yield of such
holes is about 1 mM per 10 kGy of absorbed irradiation dose
(as compared to 20^30 WM concentration of the heme pro-
tein); hence, at higher doses they compete for the new elec-
trons with almost 100% e⁄ciency, and further irradiation
above the doses of 20^30 kGy does not result in formation
of new product.
To overcome this di⁄culty and to increase the yield of
radiolytic reduction, we used multiple photolysis of the
trapped electrons, which stimulated their recombination with
positive holes. In Fig. 1 the absorption spectra of oxy-ferrous
HO before and after incubation for 20 h in the presence of 32P
(estimated dose 2.2 kGy) are shown. The broad band corre-
sponding to the absorption of the electron trapped in aqueous
glycerol [31] is the dominating feature before photobleaching
(Fig. 1B). As a result of photobleaching, most of the trapped
electrons disappear through the recombination with the im-
mobilized positive holes, as well as through the reduction of
other acceptors, and the spectrum of the heme enzyme can be
clearly seen (Fig. 1C). After this process is completed, the
remaining concentration of positive holes is minimized, and
further irradiation produces much more radiolytically reduced
target species than without such treatment.
The cryoradiolysis of heme proteins using Q-rays [16^19,22^
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Fig. 1. Spectra of oxy-HO in the presence of 32P phosphate (0.1 M
phosphate, pH 7.0, 70% glycerol, 10 mCi/ml activity, T=80 K).
A: 30 min (50 Gy accumulated dose). B: 21 h (2.2 kGy accumu-
lated dose). C: The same as B, after 8 min photobleaching at 77 K.
See [24] for other experimental details.
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Fig. 2. Conversion of oxy-HO to hydroperoxo-HO with dose accu-
mulation from 32P phosphate (0.1 M phosphate, pH 7.0, 70% glyc-
erol, T=80 K). A: initial spectrum of oxy-HO before irradiation.
B: Spectrum of hydroperoxo-HO, calculated from the experimental
spectra measured at di¡erent irradiation doses.
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Fig. 3. Annealing of irradiated oxy-HO at 210 K (A),215 K (B),
220 K (C), and after thawing at 270 K (D). The sample was Q-irra-
diated using a 60Co source with the total estimated dose of 44 kGy.
The calculated reduction yield was 34%, the rest of the enzyme re-
mained in oxy-ferrous form.
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25], X-rays [18,20,21], or 32P phosphate (L-rays) [24] results in
a one-electron reduction of the heme iron. We have measured
the spectra of cryoreduced ferric HO at 77 K and after an-
nealing at di¡erent temperatures in the range 80^220 K (not
shown), and used them as a reference, including the direct
control of possible non-speci¢c heme degradation during ra-
diolysis. No sign of heme degradation was detected after an-
nealing of radiolytically reduced ferric HO. Instead, the en-
zyme was converted to Fe2þ-CO form, due to reduction by
accumulated organic radicals and subsequent binding of CO,
formed as the product of glycerol radiolysis [32^33]. This was
also seen in our cryoradiolytic studies of cytochromes P450
[24^25] and peroxidase [26].
Fig. 2 shows the gradual disappearance of oxy-HO and
formation of hydroperoxo-ferric HO at 77 K with radiation
dose accumulation. The ¢nal yield of FeP-OOH intermediate
is estimated as 85%O5% at maximum dose 70 kGy. The spec-
trum of this intermediate, calculated from the data in Fig. 2, is
shown as Fig. 2B. The Soret band is shifted to 421 nm and
has an amplitude slightly lower than that at the spectrum of
oxy-HO (maximum at 416 nm). The Q bands at 530 nm and
557 nm are blue-shifted and less separated (915 cm31 di¡er-
ence between the maxima), as compared to oxy-HO (540 nm
and 575 nm, 1130 cm31 di¡erence). To our knowledge, the
spectrum (Fig. 2B) is the ¢rst example of a well-resolved di-
rectly measured optical spectrum of an isolated FeP-OOH
enzyme complex with histidine as a proximal ligand. The
main features of this spectrum are in a good agreement with
the transient absorption spectra, measured in fast mixing
studies of the reaction of H2O2 with heme proteins [12^14],
and with our recent results obtained for the same complex in
horseradish peroxidase [26].
Annealing of the samples of hydroperoxo-ferric HO up to
200 K did not result in formation of new species (Fig. 3A). At
212^215 K the spectra undergo more signi¢cant changes, the
primary FeP-OOH intermediate begins to disappear, and the
transient species with the weaker Soret band at 406 nm is
formed (Fig. 3B). This spectrum is characteristic for the ferric
K-meso hydroxyheme, the product of heme oxygenation by
HO. Once formed, it is quickly reduced by products of glyc-
erol radiolysis and then binds CO (Fig. 3C). At higher tem-
peratures, after thawing, the rest of the heme is also converted
to the Fe2þ-CO form of K-meso hydroxyheme and further,
verdoheme (Fig. 3D). The reference experiments with cryo-
radiolytic reduction of the ferric HO do not show any forma-
tion of these product complexes in the annealing experiments.
However, after thawing and aerobic mixing of the solution of
cryoreduced ferric HO, the spectra of Fe2þ-CO forms of K-
meso hydroxyheme-HO and verdoheme-HO complexes were
observed. The control experiments with ferric HO con¢rmed
that the enzyme remains catalytically active after radiolytic
reduction, and is still able to oxidize the bound heme using
atmospheric oxygen and exogenous reductants. No heme deg-
radation has been detected in similar experiments with other
oxy-ferrous heme enzymes [24^26].
Collectively, these results show that the HO is a unique
enzyme which is able to catalyze heme degradation using at-
mospheric oxygen and exogenous reductants through a highly
stereospeci¢c arrangement of the active FeP-OOH intermedi-
ate favorable for the heme hydroxylation at the K-meso posi-
tion. This speci¢c stereochemistry includes a highly bent struc-
ture of coordinated dioxygen in oxy-ferrous HO precursor
complex [34^36]. We directly observed the one-electron reduc-
tion of this precursor and formation of the active intermediate
(Fig. 2). As previously shown by EPR and ENDOR [23], the
immediate product of this reduction, peroxo-ferric HO com-
plex, is protonated already at 77 K due to the proton transfer
from nearby water molecules, stabilized in a proper position
by the side chain of Asp140 [23,36]. The FeP-OOH active
intermediate transforms into a product, K-meso hydroxyheme,
after annealing at temperatures above 210 K. In contrast,
ferric HO, or oxy-ferrous complexes of other heme enzymes
[24^26] do not form any such heme degradation product
under identical conditions. Further studies of FeP-OOH inter-
mediate will help to dissect the most important factors of
oxygen activation by heme enzymes and bring better under-
standing of the chemical mechanisms of these reactions.
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